NYSE:ZTSPharmaceuticals
Does the Recent FDA Nod for Apoquel Signal Upside for Zoetis in 2025?
If you have Zoetis stock or are thinking about getting in, you probably have one big question right now: is this the right time, or should you keep waiting? With Zoetis, it is not just about animal health; it is also about your financial well-being. Let us take a confident, closer look at where things stand.
Over the past month, Zoetis shares have gained around 6.4%, showing some recovery momentum after a tough start to the year. Despite a 3.6% dip in year-to-date returns and a drop of 13%...